Phase 1b study of the oral gemcitabine ‘Pro-drug’ LY2334737 in combination with capecitabine in patients with advanced solid tumors
Infante, Jeffrey R., Benhadji, Karim A., Dy, Grace K., Fetterly, Gerald, Ma, Wen Wee, Bendell, Johanna, Callies, Sophie, Adjei, Alex A.Volume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0207-9
Date:
April, 2015
File:
PDF, 825 KB
english, 2015